Aciloc 150mg

🔍 Why Choose Aciloc 150 mg?

Aciloc 150 mg is the Indian equivalent of Zantac® 150 mg. Ranitidine is an H₂-receptor antagonist that suppresses gastric‑acid secretion. After the 2019‑2020 global recalls over NDMA, Cadila reformulated and now releases batch certificates guaranteeing NDMA ≤ 0.032 ppm.

🩺 Evidence‑Based Uses

• Night‑time GERD symptoms (nocturnal acid break‑through)
• Healing & maintenance of duodenal and gastric ulcers
• NSAID‑induced ulcer prophylaxis where PPIs unsuitable
• Stress‑ulcer prevention in low‑moderate ICU risk (oral route)

📋 Dosage & Administration

• Standard GERD / Ulcer: 150 mg BID for 4‑8 weeks
• Maintenance: 150 mg once nightly
• Zollinger‑Ellison: 150 mg q8h; titrate to acid output

Swallow whole with water; take bedtime dose to maximize night‑time pH control.

⚠️ Safety, NDMA & Alternatives

NDMA forms on prolonged warm storage. Cadila ships under temperature‑controlled logistics and uses PVDC alu‑alu blisters.

• Common AEs: Headache, constipation, diarrhea (≤ 3 %)
• Serious (rare): Elevated LFTs, cytopenia
• Interactions: pH‑dependent drugs (ketoconazole, atazanavir)

🌍 Import Regulations (April 2025)

💰 Price Comparison

👩‍⚕️ Doctor’s Note – Dr Sara Kulkarni

“For selected patients needing nocturnal acid suppression, NDMA‑tested ranitidine like Aciloc 150 mg remains useful. Limit therapy to 12 weeks and verify COA.”

🔗 Internal Alternatives

• Famocid 40 mg – Famotidine (NDMA‑free)
• Pan 20 mg – Pantoprazole PPI
• Omez 20 mg – Omeprazole
• Razo 20 mg – Rabeprazole
• Nexpro 20 mg – Esomeprazole

📚 References

• PubMed NDMA Study
• WHO Drug Alerts
• Drugs.com Ranitidine